August 13, 2025 - 12:48

In a recent development, Chinese authorities have expressed concerns regarding the use of Nvidia's H20 chips by local companies, including prominent tech firms like ByteDance, the parent company of TikTok. The government is encouraging these businesses to shift their focus towards domestic suppliers for their technological needs. This move appears to be part of a broader strategy to bolster China's self-sufficiency in the semiconductor industry and reduce reliance on foreign technology.
The push for local sourcing comes amid rising tensions between China and the United States, particularly in the tech sector. Officials believe that fostering a robust domestic supply chain will not only enhance national security but also stimulate local innovation and economic growth. Companies are now faced with the challenge of balancing their technological requirements with government directives, as they navigate the complexities of an evolving global market. The emphasis on domestic suppliers could reshape the landscape of technology procurement in China, impacting both local and international firms.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...